Aytu Bioscience Inc., of Englewood, Colo., completed its tender offer to amend and exercise certain categories of warrants issued to investors that participated in its May 2016 and October 2016 financings. The company said gross proceeds were approximately $2.2 million, with net proceeds totaling approximately $2 million. The company did not disclose specific use of proceeds. On Wednesday, the company's shares (OTCQX:AYTU) lost 1 cent to close at 93 cents.